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ABSTRACT
Sedation helps patients to tolerate uncomfortable gastrointestinal endoscopy procedures by relieving 
anxiety and pain. It also decreases a patient’s risk of physical injury during gastrointestinal endoscopy 
procedures while providing the endoscopist with a good environment for an optimum examination. Not all 
sedation in gastrointestinal endoscopy is managed by an anesthesiologist. Using sedation has increases risk 
of cardiopulmonary complications. Therefore, sedation is an important part in gastrointestinal endoscopy to 
learn. This review will focus on basic pharmacology of sedatives and analgesic, common used drugs in sedation 
(Propofol, Midazolam, Fentanyl), and their use in gastrointestinal endoscopy.
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ABSTRAK
Sedasi membantu pasien mentoleransi prosedur endoskopi gastrointestinal yang tidak nyaman dengan cara 
meredakan rasa cemas dan nyeri. Sedasi juga mengurangi risiko terjadi cidera fisik selama prosedur endoskopi 
gastrointestinal dan memfasilitasi endoskopis agar dapat melakukan pemeriksaan dengan optimal. Tidak semua 
pemberian obat sedasi pada tindakan endoskopi dikerjakan oleh seorang anestesiologis. Penggunaan obat 
sedasi memiliki risiko terjadinya gangguan kardiopulmonar. Oleh sebab itu, sedasi merupakan bagian penting 
untuk dipelajari dalam prosedur endoskopi gastrointestinal. Ulasan ini akan fokus membahas mengenai dasar 
farmakologi obat hipnotik-sedatif dan analgesia, jenis obat yang umum digunakan (Propofol, Midazolam, 
Fentanyl) serta penggunaannya pada tindakan endoskopi gastrointestinal.
Kata kunci: sedasi; endoskopi; analgesia; sedasi endoskopi
INTRODUCTION
Sedation, which can be defined as a drug-induced 
depression in the level of consciousness, is an 
important part in gastrointestinal endoscopy. Sedation 
helps patients to tolerate uncomfortable procedures 
by relieving anxiety, discomfort, and pain. It also 
decreases a patient’s risk of physical injury during 
endoscopic procedures while providing the endoscopist 
with a good environment for an optimum examination.1 
There are some sedatives and analgesics that can be 
used to achieve appropriate levels of sedation for 
gastrointestinal endoscopy.2
Although there are benefits from using sedatives and 
analgesics in gastrointestinal endoscopy procedures, 
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there are other things that should be considered. 
Sedation delays patient recovery and discharge. 
Sedation also increases overall cost, and the risk of 
cardiopulmonary complications.1 Sedation is divided 
into four levels, mild sedation, moderate sedation, deep 
sedation, and general anesthesia (Table 1).3 Individuals 
have different responds to sedatives. Patient may 
become more deeply sedated than the level that was 
intended.1 Therefore, basic pharmacology of sedatives 
and physiology is necessary to increases the likelihood 
to achieve targeted level of sedation. Practitioners in 
endoscopy unit should have the skills necessary to 
resuscitate or rescue a patient whose level of sedation 
is deeper than that planned.3
The aim of this review is to provide the reader 
with an overview of the current knowledge of the 
pharmacology of sedatives and analgesics, common 
used drugs in sedation (Propofol, Midazolam, 
Fentanyl), and their use in gastrointestinal endoscopy.
PHARMACOLOGY
Endoscopist should understand the pharmacology, 
pharmacokinetics (time of onset, peak response, and 
duration of effect), pharmacodynamics, adverse effect 
and drugs interactions. The most common used sedatives 
and analgesics are propofol, benzodiazepine (especially 
midazolam) and opioid (especially fentanyl).4
Propofol
Propofol is a drug that belongs to sedative-hypnotic 
class. Propofol also has anti-emetic and amnesia effects.5 
Propofol is available for intravenous use. It’s available for 
intravenous administration as an oil-in-water emulsion 
containing soybean oil, glycerol and egg lecithin. A 
history of egg allergy doesn’t necessarily contraindicate 
the use of propofol because most egg allergies involve 
reaction to egg white (albumin), whereas egg lecithin is 
extracted from egg yolk. Propofol often causes pain at 
the injection site that can be reduced by prior injection of 
lidocaine. Propofol can be a good medium for bacterial 
growth, therefore propofol should be used within 6 hours 
of the ampoule opening.6,7
Propofol works by facilitating γ-aminobutyric acid 
(GABA), the inhibitory neurotransmitter, especially at 
GABAA receptors. Activation of this receptor causes 
hyperpolarization of the nerve membrane. Propofol 
also acts on glycine, nicotinic and muscarinic receptors 
in the spinal cord and brain.6,8
Propofol has a rapid onset of action and short 
recovery time. The depth of sedation increases in a 
dose-dependent manner. The titration of propofol to 
the desired level of sedation, not too deep, requires 
a good clinical assessment of the patients.5 Propofol 
is usually combined with opioid and benzodiazepine 
drugs. The interactions between these drugs create 
synergistic sedative-hypnotic effects with each other.9
Propofol is highly lipophilic, therefore it can 
quickly cross the blood-brain barrier, which causes 
rapid onset of action. It also causes the emergence from 
sedation is quite qrapid due to its fast redistribution 
to peripheral tissues. Sedation with propofol can be 
achieved by bolus or continuous infusion. Propofol 
can make the patient unconscious within 30 seconds. 
Regardless of the duration of sedation, recovery from 
the propofol effect occurs within 10-20 minutes after 
discontinuation of the drug.5 Propofol also has an 
anti-emetic effect and less delirium occurrence after 
recovery than other intravenous sedation drugs. It 
makes propofol a good sedation drugs for outpatients 
sedation. Propofol is conjugated in the liver, resulting 
inactive metabolites that are excreted through urine.6 
Relative dose of propofol does not need adjustment in 
patients with hepatic or renal impairment.10,11
The major side effects of propofol on the 
cardiovascular system are decreased in arterial blood 
pressure due to decreased systemic vascular resistance, 
preload and cardiac contractility. Transient decreases 
in blood pressure are more prominent in large doses, 
rapid injections and geriatric patients. Propofol has 
a profound effect of respiratory depression. This is 
because propofol inhibits hypoxic ventilation drive and 
depress the normal respone to hypercarbia. Propofol 
also decrease cerebral blood flow and intracranial 
pressure.6
Table 1. Definition of general anesthesia and levels of sedation3
Minimal sedation 
(anxiolysis)
Moderate sedation 
(conscious sedation) Deep sedation General anesthesia
Responsiveness Normal respone to 
verbal stimulation
Purposeful respone to verbal 
or tactile stimulation
Purposeful respone after 
repeated or painful stimulation
Unarousable, even with painful 
stimulus
Airway Unaffected No intervention required Intervention may be required Intervention often required
Spontaneous 
ventilation
Unaffected Adequate Maybe inadequate Frequently inadequate
Cardiovascular 
function
Unaffected Maintained Usually maintained Maybe impaired
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Midazolam
Benzodiazepines have multiple pharmacologic 
effects that help facilitate sedation for endoscopy 
through interactions with GABA receptors. Similar 
to propofol, when benzodiazepines bind to GABAA 
receptors in the brain, inhibitory action occurs in the 
central nervous system.9 Benzodiazepines have anti-
anxiety, sedative-hypnotic, anterograde amnesia, anti-
convulsions, euphoria, and muscle relaxants effects. The 
benzodiazepine that is often used for gastrointestinal 
endoscopy sedation is midazolam. Midazolam has a 
shorter duration of action, better amnesia effects and 
superior patient satisfaction than diazepam.5,12 Midazolam 
is 1.5 to 3.5 times more potent than diazepam.5
Midazolam is a benzodiazepine class, that available 
in parenteral preparations. Midazolam lipophilic 
properties results in its rapid distribution across the 
blood-brain barrier to its site of action in the central 
nervous system. Midazolam is metabolized in the 
liver through oxidation and conjugation processes, 
and its metabolites are excreted through urine.4 
Kidney failure may prolong the duration of sedation 
in patients receiving midazolam due to its metabolites 
accumulation (alpha-hydroxymidazolam).6 Midazolam 
onset of action occurs within 1 to 2.5 minutes, the peak 
effect is achieved in 3 to 4 minutes, and the duration 
of effect is 15 to 80 minutes. The duration of effect of 
midazolam depends on the duration of its administration. 
Midazolam excretion decreases in geriatric, obesity 
patients, and those with hepatic and renal disorders.4.13,14
The major side effects of midazolam are respiratory 
depression, respiratory arrest, and hypotension. The 
effect of respiratory depression is dose dependent. It’s 
due to the depression of the central ventilator response 
to hypoxia and hypercapnia. However, paradoxical 
reactions, include hyperactive and aggressive behaviors 
have been reported in benzodiazepine. Flumazenil is 
a specific benzodiazepine-competitive antagonist. 
Flumazenil is useful for reversing the effects of 
benzodiazepines. It is the management for overdoses 
of benzodiazepines. Despite its rapid effect (< 1 min) 
in restoring the hypnotic-sedative effects, amnesia 
effects are usually unaffected in the administration of 
flumazenil. Flumazenil is given intravenously 0.2 mg/
min until it reaches the target of consciousness. The 
dose of flumazenil is usually 0.6 to 1 mg.4,6
Fentanyl
Opioid class has strong analgesic effects and 
little sedative effects. The analgesic effect of opioids 
comes from binding to opioid receptors (mu, kappa, 
delta, sigma), that present in the central and peripheral 
nervous system. It is resulting in inhibition of pain 
neurotransmission. Opioids can be used orally, 
rectally, transdermal, subcutaneously, intramuscularly 
and intravenously. For gastrointestinal endoscopy 
procedures, it is usually used intravenously. Among 
others opioid-type drugs, fentanyl is the most widely 
used for gastrointestinal endoscopy sedation.9
Fentanyl is a synthetic opioid. It is lipid-soluble, and 
80 to 100 times more potent than morphine. The onset 
of action for fentanyl is 1 to 2 minutes, the duration of 
effect is 30 to 60 minutes.4 Its potency is strong due to 
its high lipophilic properties, which is also the reason 
for its rapid penetration to the central nervous system. 
Elimination of fentanyl is similar to other lipophilic 
drugs. It is determined by its distribution into adipose 
tissue.9 Fentanyl binds to opioid receptors, and inhibits 
the release of pain neurotransmitters by lowering 
intracellular Ca2+ levels. Fentanyl is commonly used 
with drugs with sedative-hypnotic effects for sedation 
in gastrointestinal endoscopy.5 Fentanyl is metabolized 
in the liver and excreted through urine.4 Fentanyl 
pharmacokinetics are unchanged in patients with renal 
impairment. Prolonged use results in accumulation of 
metabolites, but it’s inactive and not toxic.9
Common side effects of opioids include respiratory 
depression, nausea, vomiting, constipation, urinary 
retention, myosis, and myoclonus. Respiratory 
depression occurs in a dose-dependent manner, and 
the concomitant use of other sedative-hypnotic drugs 
with an opioid has a synergistic effect on the risk of 
respiratory depression. Opioids usually cause only mild 
hemodynamic disorders.9 Among other opioids, fentanyl 
has relative small effect on cardiovascular system.1 
Nausea and vomiting results from stimulation of the 
chemoreceptor trigger zone in medulla, which occurs 
in dose-independent manner.6 Naloxone is an opioid 
receptor antagonist. It is used to reverse the effects 
of opioids. The onset of action for naloxone is 1 to 2 
minutes and the duration of action is 30 to 45 minutes.4
SEDATION IN ACTUAL ENDOSCOPY PRACTICES
Implementation of evidence-based sedatives and 
analgesics may improve the quality of sedation practice 
and reduce the incidence of sedation-related adverse 
events. The combination of experience and basic 
knowledge is required in the administration of sedatives 
for safe and effective induction and maintenance. 
Nowadays, the technique that often used is balanced 
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anesthesia technique. Balanced anesthesia involves 
the administration of a mixture of small amounts of 
several sedatives or analgesics. This technique allows 
us to reach the desired level of consciousness with 
minimizing the likelihood of a dose-related adverse 
reaction from any of the individual drugs. Practical 
sedation drugs for gastrointestinal endoscopy can be 
seen in Table 2.4
Table 2. Practical sedation regimens for gastrointestinal 
endoscopy
Drugs Dose
Midazolam only
Midazolam + 
Fentanyl
Propofol only
Bolus
Continuous
Propofol + Midazolam
Propofol + Fentanyl
Initial dose: 1–2 mg or 0.03 mg/kg
Additional dose: 1 mg or 0.02–0.03 mg/
kg (every 2-3 mins)
Initial dose: Midazolam 0.5-1 mg + 
Fentanyl 12.5-75 μg
Additional dose: Midazolam 1 mg or 
Fentanyl 12.5-50 μg (every 1-3 mins)
Initial dose: 10-60 mg
Additional dose: 10-20 mg (every 30 
secs)
Continuous infusion: 2-5 mg/kg/hr or 
100-200 mg/hr, with or without initial 
bolus 0.25-0.5 mg/kg
Initial dose: Midazolam 0.5-2.5 mg + 
Propofol 10-40 mg or up to 0.5 mg/kg
Additional dose: Propofol 5-20 mg 
(severy 30 secs)
Initial dose: Fentanyl 25-75 μg + 
Propofol 10-40 mg or up to 0.5 mg/kg
Additional dose: Propofol 5-20 mg 
(every 30 secs)
Zhang et al performed a meta-analysis about the 
comparisson of propofol and midazolam for sedation 
in gastrointestinal endoscopy. Data show propofol 
has higher incidence of hypotension than midazolam. 
However, propofol has higher satisfaction score than 
midazolam according to endoscopists. There was no 
significant difference in satisfaction score according 
to patient.15
Midazolam is the most widely used benzodiazepine 
for gastrointestinal endoscopy sedation due to its rapid 
onset of action and short recovery time compared to 
other benzodiazepines.4,16 Barriga et al evaluated the use 
of midazolam alone compared to midazolam combined 
with fentanyl for gastrointestinal endoscopy sedation. 
From the endoscopist point of view, patients in the 
combination group had better tolerance than midazolam 
alone group. There was no significant difference in 
duration of action and side effects between two groups.17
According to Singh et al, the use of single dose 50 
μg fentanyl combined with propofol reduces the need 
of propofol in sedation practice, without affecting the 
recovery time.18 The research of Yoon et al compared the 
use of propofol alone and propofol combined with other 
sedatives or analgesics in gastrointestinal endoscopy. 
There was no significant difference in the incidence 
of sedation-related adverse (respiratory distress, 
hypotension, arrhythmia), recovery time, duration of 
action, endoscopist and patient satisfaction between 
both groups. However, the average dose of propofol 
used was higher in propofol alone group.19
CONCLUSION
Various sedatives drugs are used to facilitate sedation 
in gastrointestinal endoscopy, either used as a single 
agent or combined. It is important for endoscopists 
to understand the basic pharmacology of hypnotic-
sedative drugs and analgesics that used in sedation 
practices, because not all sedation in gastrointestinal 
endoscopy is managed by an anesthesiologist. The 
combination of experience and basic knowledge is 
required to optimize the use of sedatives drugs in 
gastrointestinal endoscopy and decrease the incident 
of sedation-related adverse event.
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